Serum and urine trypsinogen activation peptide in assessing post-endoscopic retrograde cholangiopancreatography pancreatitis

Pancreas

Volumn 39, Issue 1, 2010, Pages 108-110

  Pezzilli, Raffaele ^a   Mariani, Alberto ^b   Gabbrielli, Armando ^c   Morselli Labate, Antonio M ^a   Barassi, Alessandra ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; GABEXATE MESILATE; MIDAZOLAM; NONSTEROID ANTIINFLAMMATORY AGENT; PROPOFOL; TRYPSINOGEN; TRYPSINOGEN ACTIVATION PEPTIDE;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADULT; AGED; BILIARY TRACT DRAINAGE; CANNULATION; CHOLANGITIS; CHOLELITHIASIS; CLINICAL ASSESSMENT; COMMON BILE DUCT; COMMON BILE DUCT STENOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; EARLY DIAGNOSIS; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; JAUNDICE; LETTER; LITHOTRIPSY; MAJOR CLINICAL STUDY; MALE; PANCREAS DUCT STENOSIS; PANCREAS TUMOR; POSTOPERATIVE ANALGESIA; POSTOPERATIVE PAIN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN URINE LEVEL; SPHINCTEROTOMY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; FEMALE; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; PANCREATITIS; RADIOIMMUNOASSAY; TIME FACTORS; YOUNG ADULT;

EID: 74049129341     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3181bab5fb     Document Type: Letter

References (10)

1. Frossard JL. Trypsin activation peptide (TAP) in acute pancreatitis: from pathophysiology to clinical usefulness. JOP. 2001;2:69-77.
2. Simpson KW, Beechey-Newman N, Lamb CR, et al. Cholecystokinin-8 induces edematous pancreatitis in dogs associated with short burst of trypsinogen activation. Dig Dis Sci. 1995;40:2152-2161.
3. Pezzilli R, Venturi M, Morselli-Labate AM, et al. Serum trypsinogen activation peptide in the assessment of the diagnosis and severity of acute pancreatic damage: a pilot study using a new determination technique. Pancreas. 2004; 29:298-305.
4. Masci E, Cavallini G, Mariani A, et al. Gabexate in Digestive EndoscopyVItalian Group II. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis. Am J Gastroenterol. 2003;98:2182-2186.
5. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335: 909-918.
6. Bradley EL. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, GA, September 11 through 13, 1992. Arch Surg. 1993;128: 586-590.
7. Masci E, Toti G, Mariani A, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001;96:417-423.
8. Karanjia ND, Widdison AL, Jehanli A, et al. Assay of trypsinogen activation in the cat experimental model of acute pancreatitis. Pancreas. 1993;8:189-195.
9. Pezzilli R, Romboli E, Campana D, et al. Mechanisms involved in the onset of post-ERCP pancreatitis. JOP. 2002;3: 162-168.
10. Chen CC, Wang SS, Lee FY. Action of antiproteases on the inflammatory response in acute pancreatitis. JOP. 2007; 8(suppl 4):488-494.